Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders

OBJECTIVE: To evaluate plasma neurofilament light (NfL) levels in autoimmune neurologic disorders (AINDs) and autoimmune encephalitis (AE). BACKGROUND: Each particular neural autoantibody syndrome has a different clinical phenotype, making one unifying clinical outcome measure difficult to assess. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Kammeyer, Ryan, Mizenko, Christopher, Sillau, Stefan, Richie, Alanna, Owens, Gregory, Nair, Kavita V., Alvarez, Enrique, Vollmer, Timothy L., Bennett, Jeffrey L., Piquet, Amanda L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924486/
https://www.ncbi.nlm.nih.gov/pubmed/35309573
http://dx.doi.org/10.3389/fneur.2022.689975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924486/
https://www.ncbi.nlm.nih.gov/pubmed/35309573
http://dx.doi.org/10.3389/fneur.2022.689975

Ejemplares similares